Vir Biotechnology, Inc.
VIRNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $1.79B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $4.82$12.00
- Volume (live)
- -
- Avg. volume (3M)
- 2.07M
Vir Biotechnology (VIR) Stock Price & Financial Analysis
Vir Biotechnology Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $10.03 - $10.59 |
|---|---|
| 52-Week High | $12.00 |
| 52-Week Low | $4.82 |
| Open | $10.36 |
| Volume (last close) | 1.69M |
| Average Volume (3M) | 2.07M |
| Revenue (TTM) | 303.20M |
|---|---|
| Net Income (TTM) | -251.68M |
| Free Cash Flow (TTM) | -203.59M |
| EPS (TTM) | −$1.69 |
| Profit Margin | -83.01% |
| Operating Margin | -88.68% |
| Return on Equity (ROE) | -25.62% |
| Debt to Equity | 0.09 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 1.79B |
|---|---|
| Shares Outstanding | 168.88M |
| Price to Sales (P/S) | 5.89 |
| Price to Book (P/B) | 1.82 |
| EV/EBITDA | -5.97 |
| 50-Day MA | $10.64 |
|---|---|
| 200-Day MA | $9.32 |
| 1-Year Change | +80.45% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Vir Biotechnology at a Glance
As of the Oct 23, 2026 close, Vir Biotechnology (VIR) has a market capitalization of $1.79B. The stock trades at 5.9× sales. Over the trailing twelve months it lost $251.68M on revenue of $303.20M and burned $203.59M of free cash flow. Revenue grew 1494.2% year over year.
As of its latest reported balance sheet, it holds $278.73M in cash and securities against $93.27M of debt, a net cash position of $185.46M.
Vir Biotechnology does not currently pay a dividend.
The share price is up 80.4% over the past year. At $10.57 (the Oct 23, 2026 close) it sits within its 52-week range of $4.82 to $12.00, above its 200-day moving average of $9.32.
Based on 8 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $21.29, 101.4% above the Oct 23, 2026 close.
Frequently Asked Questions About Vir Biotechnology
What is the current stock price for VIR?
As of the Oct 23, 2026 close, VIR stock trades at $10.57. The 52-week range is $4.82–$12.00, with a day range of $10.03–$10.59.
What is the P/E ratio for VIR?
The P/E ratio (Price-to-Earnings) for VIR is shown in the Key Statistics section. This valuation metric helps compare Vir Biotechnology, Inc. to industry peers.
Does VIR pay dividends?
Vir Biotechnology does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for VIR?
Based on ratings from 8 professional analysts over the last 90 days, the consensus for VIR is Buy. The average 12-month price target is $21.29, a 101.4% upside from the Oct 23, 2026 close of $10.57.
What is the market cap of VIR?
As of the Oct 23, 2026 close, Vir Biotechnology's market capitalization is $1.79B, classifying it as a small-cap company. Vir Biotechnology operates in the Healthcare sector within the Biotechnology industry.